# Prognostic Impact of Guideline-recommended Timing for Invasive Strategy in NSTEMI

> **NCT07204847** · — · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 407 (actual)

## Conditions studied

- NSTEMI
- NSTE-ACS (NSTEMI and UA)
- NSTEMI - Non-ST-Segment Elevation Myocardial Infarction

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07204847
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-01
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-06-20
- **Target enrollment:** 407 (ACTUAL)
- **Last updated:** 2025-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07204847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07204847, "Prognostic Impact of Guideline-recommended Timing for Invasive Strategy in NSTEMI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07204847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*